Clinical Trial

The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 22, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study was to compare the effect-site target concentration (including EC₅₀ and EC₉₀) of remifentanil required to suppress cardiovascular responses to tracheal intubation during anesthesia induction with etomidate combined with either lidocaine or sufentanil.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-07-20; most recent amendment 2025-09-17.
Status change: Not Yet Recruiting → Recruiting 2025-08-03
Trial Details
NCT Number NCT07089173
Lead Sponsor Peking University Shenzhen Hospital
Conditions Hemodynamics
Enrollment 99 participants
Start Date 2025-08-01
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-07-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-22